Cover Image
Market Research Report

North America Stroke Management Market (2018 - 2024)

Published by KBV Research Product code 763780
Published Content info 82 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Stroke Management Market (2018 - 2024)
Published: December 20, 2018 Content info: 82 Pages
Description

The North America Stroke Management Market would witness market growth of 6.8% CAGR during the forecast period (2018 - 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region would further add to the market attractiveness in the region.

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Stroke Management Market, by Type
    • 1.4.2 North America Stroke Management Market, by Application
    • 1.4.3 North America Stroke Management Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Players Outlook for the Market
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. North America Stroke Management Market by Type

    • 3.1.1 North America Diagnostics Stroke Management Market by Country
      • 3.1.1.1 North America Stroke Management Market by Diagnostics Type
        • 3.1.1.1.1 North America Stroke Management Computed Tomography Scan (CT Scan) Market by Country
        • 3.1.1.1.2 North America Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
        • 3.1.1.1.3 North America Stroke Management Echocardiography Market by Country
        • 3.1.1.1.4 North America Stroke Management Carotid Ultrasound Market by Country
        • 3.1.1.1.5 North America Stroke Management Cerebral Angiography Market by Country
        • 3.1.1.1.6 North America Stroke Management Electrocardiography Market by Country
        • 3.1.1.1.7 North America Other Diagnostics Type Stroke Management Market by Country
    • 3.1.2 North America Therapeutics Stroke Management Market by Country
      • 3.1.2.1 North America Stroke Management Market by Therapeutics Type
        • 3.1.2.1.1 North America Tissue Plasminogen Activator Stroke Management Market by Country
        • 3.1.2.1.2 North America Anticoagulant Stroke Management Market by Country
        • 3.1.2.1.3 North America Antiplatelet Stroke Management Market by Country
        • 3.1.2.1.4 North America Other Therapeutics Type Stroke Management Market by Country

Chapter 4. North America Stroke Management Market by Application

    • 4.1.1 North America Ischemic Stroke Management Market by Country
    • 4.1.2 North America Haemorrhagic Stroke Management Market by Country

Chapter 5. North America Stroke Management Market by Country

  • 5.1 US Stroke Management Market
    • 5.1.1 US Stroke Management Market by Type
      • 5.1.1.1 US Stroke Management Market by Diagnostics Type
      • 5.1.1.2 US Stroke Management Market by Therapeutics Type
    • 5.1.2 US Stroke Management Market by Application
  • 5.2 Canada Stroke Management Market
    • 5.2.1 Canada Stroke Management Market by Type
      • 5.2.1.1 Canada Stroke Management Market by Diagnostics Type
      • 5.2.1.2 Canada Stroke Management Market by Therapeutics Type
    • 5.2.2 Canada Stroke Management Market by Application
  • 5.3 Mexico Stroke Management Market
    • 5.3.1 Mexico Stroke Management Market by Type
      • 5.3.1.1 Mexico Stroke Management Market by Diagnostics Type
      • 5.3.1.2 Mexico Stroke Management Market by Therapeutics Type
    • 5.3.2 Mexico Stroke Management Market by Application
  • 5.4 Rest of North America Stroke Management Market
    • 5.4.1 Rest of North America Stroke Management Market by Type
      • 5.4.1.1 Rest of North America Stroke Management Market by Diagnostics Type
      • 5.4.1.2 Rest of North America Stroke Management Market by Therapeutics Type
    • 5.4.2 Rest of North America Stroke Management Market by Application

Chapter 6. Company Profiles

  • 6.1 B. Braun Melsungen AG.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 ABBOTT
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional & Segmental Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Cardinal Health
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental Analysis
  • 6.4 Medtronic Plc.
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental and Regional Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 General Electric (GE) (GE Healthcare)
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Segmental and Regional Analysis
    • 6.5.4 Research & Development Expense
  • 6.6 Siemens Healthineers
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Bristol-Myers Squibb
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Merck & Company Inc.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental Analysis
    • 6.8.4 Research & Development Expense
  • 6.9 Glaxosmithkline Plc.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental Analysis
    • 6.9.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 NORTH AMERICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 2 NORTH AMERICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 3 NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 4 NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 5 NORTH AMERICA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 6 NORTH AMERICA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 7 NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 8 NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 9 NORTH AMERICA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 10 NORTH AMERICA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 11 NORTH AMERICA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 12 NORTH AMERICA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 13 NORTH AMERICA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 14 NORTH AMERICA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 15 NORTH AMERICA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 16 NORTH AMERICA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 17 NORTH AMERICA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 18 NORTH AMERICA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 19 NORTH AMERICA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 20 NORTH AMERICA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 21 NORTH AMERICA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 22 NORTH AMERICA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 23 NORTH AMERICA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 24 NORTH AMERICA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 25 NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 26 NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 27 NORTH AMERICA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 28 NORTH AMERICA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 29 NORTH AMERICA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 30 NORTH AMERICA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 31 NORTH AMERICA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 32 NORTH AMERICA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 33 NORTH AMERICA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 34 NORTH AMERICA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 35 NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 36 NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 37 NORTH AMERICA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 38 NORTH AMERICA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 39 NORTH AMERICA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 40 NORTH AMERICA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 41 NORTH AMERICA STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 42 NORTH AMERICA STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 43 US STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 44 US STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 45 US STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 46 US STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 47 US STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 48 US STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 49 US STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 50 US STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 51 US STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 52 US STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 53 CANADA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 54 CANADA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 55 CANADA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 56 CANADA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 57 CANADA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 58 CANADA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 59 CANADA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 60 CANADA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 61 CANADA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 62 CANADA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 63 MEXICO STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 64 MEXICO STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 65 MEXICO STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 66 MEXICO STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 67 MEXICO STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 68 MEXICO STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 69 MEXICO STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 70 MEXICO STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 71 MEXICO STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 72 MEXICO STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 73 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 74 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 75 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 76 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 77 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 78 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 79 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 80 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 81 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 82 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 83 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 84 KEY INFORMATION - ABBOTT
  • TABLE 85 KEY INFORMATION - CARDINAL HEALTH
  • TABLE 86 BUSINESS SEGMENT - CARDINAL HEALTH
  • TABLE 87 KEY INFORMATION - MEDTRONIC PLC
  • TABLE 88 KEY INFORMATION - MEDTRONIC
  • TABLE 89 KEY INFORMATION - GENERAL ELECTRIC (GE)
  • TABLE 90 KEY INFORMATION - SIEMENS HEALTHINEERS
  • TABLE 91 KEY INFORMATION - BRISTOL-MYERS SQUIBB
  • TABLE 92 KEY INFORMATION - MERCK & COMPANY INC.
  • TABLE 93 KEY INFORMATION - GLAXOSMITHKLINE PLC.
Back to Top